“Formulation and optimization of liquisolid tablet for improving the dissolution profile of rivaroxaban by using DoE approachand antithrombic activity” (2025) Journal of Carcinogenesis, 23(1), pp. 701–719. doi:10.64149/J.Carcinog.24.3s.812-830.